Filing Details
- Accession Number:
- 0001209191-10-017816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-18 13:00:00
- Reporting Period:
- 2010-03-17
- Filing Date:
- 2010-03-18
- Accepted Time:
- 2010-03-18 16:02:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
786947 | Acura Pharmaceuticals Inc | ACUR | Pharmaceutical Preparations (2834) | 110853640 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1058352 | G William Skelly | C/O Acura Pharmaceuticals, Inc. 616 N. North Court Palatine IL 60067 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-03-17 | 1,000 | $5.55 | 100,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Holdings listed are Restricted Stock Units and give effect to a 1 for 10 reverse stock split effective on December 5, 2007. Restricted Stock Units represent rights to an equivalent number of shares of common stock of the Issuer. Absent a change of control, 25,000 shares of common stock will be distributed under the Restricted Stock Units (after payment of $.01 par value per share) on January 1st of each 2011, 2012, 2013, and 2014. If a change of control occurs (whether prior to or after 2011), one share of common stock will be distributed for each outstanding Restricted Stock Unit (after payment of $.01 per share par value) at or about the time of the change of control.